News
In this study, we integrated multiple RNA-Seq data sets to detect candidate CRC biomarkers, investigated the pathology of CRC, guiding the development of new therapies for CRC.
AMSTERDAM, July 26, 2021 /PRNewswire/ -- CRCbioscreen, a Dutch diagnostics company, dedicated to developing a next generation stool test for population based ColoRectal Cancer or CRC screening ...
CRCbioscreen, a Dutch diagnostics company, dedicated to developing a next generation stool test for population based ColoRectal Cancer or CRC screening, today announced the publication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback